Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HB002.1T
DRUG
2 trials
Sponsors
Huabo Biopharm Co., Ltd.
Conditions
Solid Tumor
Phase 1
A Study of Injection HB002.1T in Subjects With Solid Tumor
Completed
NCT03636750
Huabo Biopharm Co., Ltd.
Solid Tumor
Start: 2018-06-28
End: 2020-03-21
Updated: 2021-07-28
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
NCT04802980
Huabo Biopharm Co., Ltd.
Solid Tumor
Start: 2020-04-28
End: 2023-09-30
Target: 72
Updated: 2021-07-28
Related Papers
A phase Ib trial of the VEGF fusion protein HB002.1T plus chemotherapy in patients with advanced solid tumors.
Journal of Clinical Oncology
2023-06-01